Related Experiment Video
Updated: Jun 22, 2025
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer
Jamaal C Jackson1, Darren Sanchez1, Andrew C Johns2
1Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
Germ cell tumor of the testis (GCT) is a curable cancer even when it is widely metastatic; however, outcomes can differ based on tumor histology. Chemo-resistance in certain phenotypes, such as teratoma and yolk sac tumor, contributes to poor clinical outcomes in some patients with GCT. Despite this resistance to S-YSTemic therapy, many of these tumor subtypes remain amenable to surgical resection and possible cure. In this study, we report on a series of seven patients highlighting two chemo-resistant subtypes of nonseminomatous germ cell tumor (NSGCT), sarcomatoid yolk sac tumor (S-YST), and epithelioid trophoblastic tumor (ETT) for which early resection rather than additional salvage chemotherapy or high-dose intense chemotherapy might provide a superior clinical outcome and enhance cure rate.
Insights
Testicular germ cell tumors (GCT) are curable, but chemo-resistance in subtypes like sarcomatoid yolk sac tumor (S-YST) and epithelioid trophoblastic tumor (ETT) poses challenges. Early surgical resection may improve outcomes for these specific nonseminomatous GCTs.
Area of Science:
- Oncology
- Cancer Research
- Urologic Oncology
Background:
- Germ cell tumors of the testis (GCT) are generally curable, but specific histologies influence treatment outcomes.
- Chemo-resistance in certain GCT subtypes, including teratoma and yolk sac tumors, can lead to poorer clinical results.
- Nonseminomatous germ cell tumors (NSGCT) encompass various subtypes with differing responses to systemic therapy.
Observation:
- This study reviewed seven patients with chemo-resistant NSGCT subtypes.
- Two specific subtypes, sarcomatoid yolk sac tumor (S-YST) and epithelioid trophoblastic tumor (ETT), were highlighted.
- These subtypes demonstrated resistance to conventional systemic therapies.
Findings:
- Sarcomatoid yolk sac tumor (S-YST) and epithelioid trophoblastic tumor (ETT) exhibit chemo-resistance.
- Early surgical resection, rather than intensive chemotherapy, may be a more effective strategy for these specific NSGCT subtypes.
- Surgical intervention shows potential for improved clinical outcomes and cure rates in these cases.
Implications:
- The findings suggest a paradigm shift in managing chemo-resistant NSGCT, specifically S-YST and ETT.
- Early surgical management could enhance cure rates and patient outcomes.
- Further research into optimal treatment strategies for rare and chemo-resistant GCT subtypes is warranted.
Related Concept Videos
02:41Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...